Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial.

Roemhild A, Otto NM, Moll G, Abou-El-Enein M, Kaiser D, Bold G, Schachtner T, Choi M, Oellinger R, Landwehr-Kenzel S, Juerchott K, Sawitzki B, Giesler C, Sefrin A, Beier C, Wagner DL, Schlickeiser S, Streitz M, Schmueck-Henneresse M, Amini L, Stervbo U, Babel N, Volk HD, Reinke P

British Medical Journal

2021 Oct

371():m3734

molg055148 [pii], 10.1136/bmj.m3734 [doi]. PMID: 33087345

Link to Publication

Newest Publications

  • Mild hypothermia provides Treg stability

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

  • Short-term cytokine stimulation reveals regulatory T cells with down-regulated Foxp3 expression in human peripheral blood

  • Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization

  • CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures

  • TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity

  • BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study

  • Gravitational stress during parabolic flights reduces the number of circulating innate and adaptive leukocyte subsets in human blood

  • A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies

  • The AICL-KLRF1 axis supports CD4-CD8 T cell communication and cytokine competence in pre-exhausted CD8+ T cells

Sawitzki Lab

Berlin Institute of Health at Charité (BIH) 
Center of Immunomics/Translational Immunology

Luisenstraße 65 
D-10117 Berlin

© 2026